The most commonly reported adverse events in Phase 2 and Phase 3 trials were gastrointestinal in nature, including nausea, diarrhea, vomiting, and constipation
Here is an honest look at what they do and who they help
Published Literature Context Published IGF-1 literature spans growth-factor characterization and preclinical IGF-1 receptor research models [2][3]
It postulates that GH has direct effects on peripheral tissues that are independent of IGF-1, apart from its capacity to stimulate local IGF-1 production in an autocrine/paracrine manner
A two-way ANOVA was performed, with significance determined by Tukeys multiple comparisons test (i.e., Fig
May Help Reduce the Risk of Autoimmune Diseases An autoimmune disorder is a condition in which the body attacks itself